Blood pressure reduction and cardiac hypertrophy by activating the kallikrein–kinin system were demonstrated in 2K1C, DOCA-Salt and spontaneously hypertensive rat models of hypertension by injection of a construct containing the human kallikrein gene [56]. This evidence concerns the gene KLK4 and hypertensive disorder.